Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin against SARS-Cov-2
Kumar Yadalam et al.,
Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin against SARS-Cov-2,
Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2022.01.049
In Silico study of melatonin, angomelatine, and ramelteon for SARS-CoV-2, predicting significant SARS-CoV-2 RBD and ACE2 binding with all three.
Kumar Yadalam et al., 25 Jan 2022, peer-reviewed, 14 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
Abstract: Journal Pre-proofs
Original article
Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin
against SARS-Cov-2
Pradeep Kumar Yadalam, Thodur Madapusi Balaji, Saranya Varadarajan,
Khalid J Alzahrani, Mohammad S. Al-Ghamdi, Hosam Ali Baeshen,
Mohammed Farhan A Alfarhan, Zohaib Khurshid, Shilpa Bhandi,
Raghunathan Jagannathan, Vikrant R. Patil, A. Thirumal Raj, Jithendra
Ratnayake, Shankargouda Patil
PII:
DOI:
Reference:
S1319-562X(22)00049-3
https://doi.org/10.1016/j.sjbs.2022.01.049
SJBS 3177
To appear in:
Saudi Journal of Biological Sciences
Received Date:
Revised Date:
Accepted Date:
19 December 2021
12 January 2022
20 January 2022
Please cite this article as: P. Kumar Yadalam, T. Madapusi Balaji, S. Varadarajan, K.J. Alzahrani, M.S. AlGhamdi, H. Ali Baeshen, M. Farhan A Alfarhan, Z. Khurshid, S. Bhandi, R. Jagannathan, V.R. Patil, A. Thirumal
Raj, J. Ratnayake, S. Patil, Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin against
SARS-Cov-2, Saudi Journal of Biological Sciences (2022), doi: https://doi.org/10.1016/j.sjbs.2022.01.049
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover
page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version
will undergo additional copyediting, typesetting and review before it is published in its final form, but we are
providing this version to give early visibility of the article. Please note that, during the production process, errors
may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
© 2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
Title page
Title: Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin against
SARS-Cov-2
Running title: Angomelatine, ramelteon, and melatonin against SARS-Cov-2
Authors and affiliation:
1) Pradeep Kumar Yadalam
Department of Periodontics, Saveetha Dental College and Hospital, Saveetha Institute of
Medical and Technical Sciences, Saveetha University, Chennai, India. Mail id:
pradeepkumar.sdc@saveetha.com
2) Thodur Madapusi Balaji
Department of Periodontology, Tagore Dental College and Hospital, Chennai, India. Mail id:
tmbala81@gmail.com
3) Saranya Varadarajan
Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and
Hospital, Chennai, India. Mail id: vsaranya87@gmail.com
4) Khalid J Alzahrani
Department of Clinical Laboratories Sciences,College of Applied Medical Sciences, Taif
University, Taif, Saudi Arabia. Mail id: ak.jamaan@tu.edu.sa
5) Mohammad S. Al-Ghamdi
Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif
University, Taif, Saudi Arabia. Mail id: abo_fares_@hotmail.com
6) Hosam Ali Baeshen
Department of Orthodontics, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi
Arabia. Mail id: drbaeshen@me.com
7) Mohammed Farhan A Alfarhan
Department of Surgery, College of Medicine, King Faisal University, Al-Ahsa, KSA.
Mail id :malfarhan002@yahoo.com
8) Zohaib Khurshid
Department of Prosthodontics and Dental Implantology, College of Dentistry, King Faisal
University, Al- Ahsa, Saudi Arabia. Mail id: zsultan@kfu.edu.sa
9) Shilpa Bhandi
Department of Restorative Dental Science, College of Dentistry, Jazan, University, Saudi
Arabia. Mail id: shilpa.bhandi@gmail.com
10) Raghunathan Jagannathan
Department of..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit